US Stocks Rise on Imminent Trade Deal with UK

The article reports on various market updates and news, including the pricing of EGH Acquisition's IPO, stocks rising in Europe and the US, and the announcement of a potential US-UK trade deal. Equity futures are mixed pre-bell, and the FTSE 100 is expected to rise. Onestream reports Q1 non-GAAP earnings that beat estimates, while Seres Therapeutics shares fall after a downgrade. The article also covers the merger of Bukit Jalil Global Acquisition 1 and Global IBO, and the trading halt of Verastem stock. Overall, the market is positive, with optimism surrounding the potential US-UK trade deal.

May 9, 2025 - The financial markets have been abuzz with various updates and news, including the pricing of EGH Acquisition Corp.'s (NASDAQ: EGHAU) initial public offering (IPO), the potential US-UK trade deal, and earnings reports from several companies.

EGH Acquisition's IPO Pricing
EGH Acquisition Corp. (NASDAQ: EGHAU) announced the pricing of its IPO on May 8, 2025. The company priced 15,000,000 units at $10.00 per unit, with the securities expected to begin trading on May 9, 2025, under the symbol "EGHAU" on the Nasdaq Global Market [1].

US-UK Trade Deal
The United Kingdom became the first country to seal a trade deal with the US, as announced on May 8, 2025. The UK's FTSE 100 closed lower following the announcement, while US major indexes rallied. The trade deal, which includes billions of dollars of increased market access for American exports, was welcomed by President Donald Trump [3].

Equity Futures and Market Sentiment
Equity futures were mixed pre-bell, with the FTSE 100 expected to rise. The Bank of England cut interest rates by 25 basis points to 4.25%, reflecting a slowdown in prices. The UK's FTSE 100 plummeted 0.32% after the UK and US announced the trade deal [3].

Earnings Reports
Onestream reported Q1 non-GAAP earnings that beat estimates, while Seres Therapeutics shares fell after a downgrade. Seres Therapeutics Inc. (MCRB) reported first-quarter net income of $32.7 million, missing Wall Street expectations [4].

Mergers and Trading Halts
Bukit Jalil Global Acquisition 1 and Global IBO announced their merger, while Verastem stock was trading on a halt. The market remains positive, with optimism surrounding the potential US-UK trade deal [3].

References:
[1] https://www.stocktitan.net/news/EGHAU/egh-acquisition-corp-announces-pricing-of-150-000-000-initial-public-tj149d72edrf.html
[2] https://seekingalpha.com/news/4445169-egh-acquisition-prices-150m-ipo
[3] https://www.cryptopolitan.com/london-market-react-to-us-uk-deal/
[4] https://www.washingtonpost.com/business/2025/05/07/earns-seres-therapeutics/eb977286-2b34-11f0-a724-3bc879c9f843_story.html